Assessment of this variant independently may be important for clinicians given the hypothesized impact of this variant specifically for postmenopausal breast cancer due to the role of HSD3B1 in adrenally mediated estrogen biosynthesis. This evidence concerns the gene HSD3B1 and breast cancer.